- Peters will oversee employee engagement, retention and acquisition as Nutcracker continues to grow
EMERYVILLE, Calif., March 7, 2023 — Nutcracker Therapeutics, Inc., a biotechnology company dedicated to developing transformative RNA therapies through its proprietary platform, today announced the appointment of Angela Peters as the company’s first Chief Human Resources Officer (CHRO). Peters joins the company amidst an ongoing strengthening of the company’s therapeutic efforts, which included the appointment of several key C-suite executives over the past year.
“I am delighted to join Nutcracker and to further build on the company’s remarkable culture of discovery and innovation – one that truly embraces breakthrough technologies to make a meaningful difference in the lives of patients,” said Peters. “I am particularly excited to come aboard at this important inflection point for the company, as it unlocks the powerful potential of RNA therapeutics. I look forward to ensuring that my colleagues have the tools, resources and opportunities to do the best work of their careers.”
Peters joins Nutcracker from Standard Biotools, formerly Fluidigm, where she served as CHRO and led major initiatives that included the global and digital transformation of HR services and functions. In conjunction with other senior leaders, she drove the evolution of the company beyond its roots in single cell genomics – delivering on talent and cultural imperatives integral to the company’s persona as a growing, high-plex imaging pioneer, as well as significant cultural programs to reinforce organizational values related to diversity, equity, and inclusion.
“Angela brings extensive experience, alongside a proven track record of elevating and transforming internal operations across the biotech industry,” said Igor Khandros, CEO. “Her presence will prove instrumental as we continue to grow and evolve as a company.”
Prior to Standard Biotools, Peters was a senior director of HR at Medivation (acquired by Pfizer), and associate vice president of HR at Thermo Fisher Scientific. She graduated with her bachelor’s degree in marketing from Notre Dame University, and later went on to complete the University of California Berkeley extension program for chief HR officers.
Peters joins several other key C-suite hires within the past year, including Chief Medical Officer Dr. Robert Schott, Chief Operating Officer Dr. John Stubenrauch, and Chief Business Officer Dr. Geoff Nosrati.
About Nutcracker Therapeutics, Inc.
Nutcracker Therapeutics, Inc. is an RNA therapeutics company that has combined the power of advanced engineering with high-precision biosynthesis to deploy a complete RNA platform that encompasses the design, delivery, and manufacturing of RNA medicines. Armed with this high-tech advantage, the company has initiated multiple therapeutic programs with the support of clinical investigators at leading institutions. Nutcracker Therapeutics’ technology platform has the potential to significantly reduce costs and cycle times for RNA therapeutic development, with dramatic advantages in speed and capacity scaling over other RNA manufacturing approaches.
For more information, visit www.nutcrackerx.com.